Susquehanna International Group, LLP Esperion Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.61 - $2.73 $120,267 - $203,931	-74,700 Reduced 14.77%	431,200 $711,000
Q2 2024 Aug 15, 2024	BUY	$1.84 - $3.24 $178,112 - $313,632	96,800 Added 23.66%	505,900 $1.12 Million
Q1 2024 May 07, 2024	BUY	$2.02 - $3.02 $212,504 - $317,704	105,200 Added 34.62%	409,100 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $138,554 - $584,584	189,800 Added 166.35%	303,900 $908,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $1.79 $17,184 - $32,041	17,900 Added 18.61%	114,100 $111,000
Q2 2023 Aug 11, 2023	SELL	$1.2 - $1.76 $21,720 - $31,856	-18,100 Reduced 15.84%	96,200 $133,000
Q1 2023 May 16, 2023	SELL	$1.46 - $7.3 $791,612 - $3.96 Million	-542,200 Reduced 82.59%	114,300 $181,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $2.31 Million - $3.85 Million	453,000 Added 222.6%	656,500 $4.09 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $750,465 - $1.12 Million	137,700 Added 209.27%	203,500 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $248,039 - $346,840	-52,000 Reduced 44.14%	65,800 $418,000
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $113,226 - $188,484	33,900 Added 40.41%	117,800 $547,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $316,017 - $783,144	-65,700 Reduced 43.92%	83,900 $420,000
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $360,612 - $679,566	-31,800 Reduced 17.53%	149,600 $1.8 Million
Q2 2021 Aug 11, 2021	SELL	$19.4 - $28.71 $331,740 - $490,941	-17,100 Reduced 8.61%	181,400 $3.84 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $1.62 Million - $2.38 Million	-64,500 Reduced 24.52%	198,500 $5.57 Million
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $3.53 Million - $5.21 Million	145,800 Added 124.4%	263,000 $6.84 Million
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $424,048 - $716,856	13,600 Added 13.13%	117,200 $4.36 Million
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $2.55 Million - $4.35 Million	-84,800 Reduced 45.01%	103,600 $5.32 Million
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $1.31 Million - $3.54 Million	47,900 Added 34.09%	188,400 $5.94 Million
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $1.49 Million - $2.52 Million	-42,100 Reduced 23.06%	140,500 $8.38 Million
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $17,235 - $23,765	-500 Reduced 0.27%	182,600 $6.69 Million
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $5.41 Million - $7.05 Million	-134,800 Reduced 42.4%	183,100 $8.52 Million
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $3.32 Million - $4.44 Million	82,800 Added 35.22%	317,900 $12.8 Million
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $16.2 Million - $25.9 Million	-438,600 Reduced 65.1%	235,100 $10.8 Million
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $5.7 Million - $7.19 Million	-139,800 Reduced 17.19%	673,700 $29.9 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $10.8 Million - $22.8 Million	298,200 Added 57.87%	813,500 $31.9 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $22.1 Million - $27.1 Million	335,400 Added 186.44%	515,300 $37.3 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $4.59 Million - $7.13 Million	105,700 Added 142.45%	179,900 $11.8 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $3.25 Million - $3.92 Million	74,200	74,200 $3.72 Million

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $146M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account